Do Parkinson’s Patients Shake in Their Sleep?

The classic Parkinson’s disease tremor, the rhythmic shaking most people associate with the condition, largely vanishes once a person falls asleep. One study measured tremor-related muscle activity and found it dropped from about 35% of the time during wakefulness to less than 4% in light sleep, under 2% in deep sleep, and essentially zero during REM sleep. That disappearance is one of the more striking features of Parkinson’s pathophysiology. But the full picture of what happens to a person with Parkinson’s disease at night is far more complicated than “the shaking stops,” and some of the nighttime movement problems that do occur get mistaken for tremor by patients and bed partners alike.

How Tremor Fades Across Sleep Stages

Parkinson’s tremor is generated by abnormal oscillating signals in a brain circuit that links the basal ganglia to the motor cortex. During wakefulness, that circuit is active and those signals produce the familiar resting tremor. As a person transitions into sleep, the brain’s electrical activity reorganizes dramatically. The oscillatory patterns that drive parkinsonian tremor weaken as consciousness fades, and the deeper someone sleeps, the more completely the tremor disappears.

Researchers have quantified this in sleep lab studies using electromyography, which measures electrical activity in muscles. In one detailed study of Parkinson’s patients, tremor-related muscle signals were present about 35% of the time during wakefulness. That figure fell to roughly 4% during light non-REM sleep, about 1.4% during deep non-REM sleep, and dropped to a mere 0.06% during REM sleep, at which point any remaining tremor was so faint it could only be detected on the recording equipment, not seen or felt.¹ The state of vigilance, meaning how awake or asleep the brain is, significantly shapes how these abnormal motor-circuit signals are expressed.²

For many patients, this means the transition periods are the worst. Lying in bed trying to fall asleep, or waking briefly in the night, can bring tremor roaring back because the brain is hovering near wakefulness. Once sleep consolidates, the tremor quiets. So if you or a bed partner notice shaking while the person with Parkinson’s is clearly still awake or drifting off, that is the expected pattern. If they appear to be fully asleep and still shaking, something else may be going on.

REM Sleep Behavior Disorder and the Movements It Causes

The most common source of nighttime movement in Parkinson’s disease is not tremor at all. It is a condition called REM sleep behavior disorder, or RBD, which affects a large proportion of people with the disease. RBD can even appear years before any classic Parkinson’s symptoms show up, making it one of the earliest signs of the underlying neurodegeneration.³

During normal REM sleep, your brain essentially paralyzes your voluntary muscles so you don’t act out your dreams. In people with RBD, that paralysis mechanism breaks down. The result is that dreamers physically perform the actions in their dreams: punching, kicking, shouting, flailing, sometimes even leaping out of bed. These movements can be violent enough to injure the person or their bed partner.

Here is the genuinely surprising part: the movements people make during RBD episodes look nothing like Parkinson’s disease. Researchers who video-recorded patients during RBD found that the movements were fast, wide-ranging, coordinated, and symmetrical, with no obvious signs of parkinsonism.¹ During the day, these same patients had pronounced asymmetric stiffness, slowness, and tremor. But during REM sleep, their movements were free of those constraints, though they were jerky, violent, and often repetitive. Even more strikingly, patients tended to use their more disabled arm and hand during RBD episodes, as if the limb that struggled most during waking hours was liberated during dream enactment.¹

The leading explanation is that during REM sleep, the brain’s motor commands take a different route, one that bypasses the basal ganglia entirely.⁴ Since the basal ganglia are the brain structures most damaged by Parkinson’s disease and responsible for generating the tremor, bypassing them means the tremor disappears and normal-speed movement returns. It is a bittersweet finding: the motor hardware works fine; it is the control circuitry that is broken during waking life.

Why RBD and Tremor-Dominant Parkinson’s Rarely Overlap

Not everyone with Parkinson’s gets RBD, and the patients who do tend to have a specific profile. Research shows that Parkinson’s patients with RBD are less likely to have tremor-dominant disease. In one study, only about 14% of Parkinson’s patients with RBD were classified as tremor-predominant, compared to 53% of Parkinson’s patients without RBD. The proportion of their overall motor disability accounted for by tremor was also much lower in the RBD group.⁵

This distinction matters practically. If a person with Parkinson’s has prominent daytime tremor, they are less likely to develop RBD and its dramatic nighttime movements. Conversely, those whose disease is dominated by stiffness, slowness, and balance problems are more likely to experience RBD. The underlying reasons probably relate to which brain regions are most affected: tremor-dominant Parkinson’s and the form that produces RBD seem to involve partially different patterns of neurodegeneration.

Periodic Limb Movements and Restless Legs

Tremor and RBD are not the only reasons a person with Parkinson’s might move during the night. Two other conditions are common in this population and easy to confuse with tremor if you are observing someone sleep.

Periodic limb movements in sleep, or PLMS, are repetitive, involuntary leg jerks that happen every 20 to 40 seconds during sleep. They look like a rhythmic flexing of the ankle, knee, or hip and can be mistaken for tremor by an observer, though the pattern is quite different. PLMS are common in Parkinson’s disease. One study found that about 58% of Parkinson’s patients had significant periodic limb movements during sleep, and the movements became more frequent as the disease progressed.⁶ Interestingly, while PLMS are highly prevalent in Parkinson’s patients, the severity of the limb movements does not appear to track neatly with the severity of the disease itself, suggesting they may be related but partly independent phenomena.⁷

Restless legs syndrome (RLS), characterized by an uncomfortable urge to move the legs that worsens at rest and in the evening, is also significantly more common in Parkinson’s disease than in the general population. Roughly 16% of Parkinson’s patients experience restless legs, compared to 5 to 10% of the general population.⁸ Both conditions share some overlap with Parkinson’s, including involvement of the dopamine system and an association with PLMS. For a bed partner watching at night, the leg movements of PLMS or the fidgeting of restless legs could easily be reported as “shaking,” even though the underlying mechanism is completely different from parkinsonian tremor.

The Opposite Problem at Night: Not Enough Movement

While the question most people ask is about shaking, the more prevalent nighttime motor problem in Parkinson’s disease is actually the opposite: an inability to move normally. This is called nocturnal hypokinesia, and it shows up primarily as difficulty turning over in bed.

Turning over in bed seems simple, but it actually involves a complex sequence of coordinated muscle contractions, especially in the trunk, hips, and shoulders. In Parkinson’s disease, the rigidity and slowness that characterize daytime movement get worse at night as medication wears off. Patients may find themselves stuck in one position for hours, unable to roll over without considerable effort. Research shows that Parkinson’s patients move significantly more slowly in bed than healthy adults, with notably reduced strength in the hip muscles that drive turning movements, along with increased arm stiffness.⁹

This immobility creates real dangers. Being stuck in one position can lead to pressure sores, pain, and poor sleep quality. In extreme cases, patients who become trapped in a prone or face-down position may be at risk for positional asphyxia.¹⁰ The inability to reposition during sleep is one of the most consistent and troublesome nighttime complaints in Parkinson’s disease, and it heavily impacts the burden on caregivers. Research has identified nocturnal akinesia, meaning this nighttime immobility, as one of the strongest independent predictors of caregiver burden, alongside the patient’s anxiety levels.

Medication Timing and Wearing Off

Much of what happens at night in Parkinson’s disease is tied to medication schedules. The standard treatment, levodopa, works by temporarily boosting dopamine levels in the brain. But each dose wears off after a few hours, a phenomenon called the “wearing off” effect. When the last evening dose fades during the middle of the night, patients experience a return of motor symptoms, including stiffness, slowness, and sometimes tremor.¹¹

This creates a window, typically in the early morning hours, where people with Parkinson’s are at their stiffest and least mobile. It is also a time when tremor can return if the person wakes up, because they are now in a state of wakefulness without adequate medication on board. Bed partners may notice this as shaking that occurs specifically during nighttime awakenings rather than during deep sleep itself.

The wearing-off pattern also means that some of the “nighttime movement problems” patients report are actually problems that occur during brief awakenings rather than during sleep proper. A person who wakes up at 3 a.m. with their medication depleted may experience tremor, stiffness, and difficulty getting comfortable, all of which can look like sleep-related problems even though they technically occur during wakefulness.

Treatments That Help at Night

Given how many different nighttime problems Parkinson’s patients face, treatment usually needs to address multiple targets. For the wearing-off problem, sustained-release or prolonged-release formulations of dopamine-boosting medications can help maintain more consistent drug levels through the night. Ropinirole in a prolonged-release form has been shown to improve nocturnal symptoms in advanced Parkinson’s patients whose sleep was not well controlled on levodopa alone.¹² Pramipexole, another dopamine agonist, has shown similar benefits in both sustained-release and immediate-release forms, with both producing clinically meaningful improvements in nighttime symptoms for advanced Parkinson’s patients.¹³

For RBD specifically, treatment typically involves safety measures like padding the bed environment and removing nearby objects that could cause injury. Medications such as clonazepam and melatonin are commonly used, though their evidence base is less robust than for the dopaminergic treatments used for other Parkinson’s symptoms.

Deep brain stimulation (DBS), a surgical treatment that involves implanting electrodes in the brain, has shown benefits for sleep quality alongside its well-known effects on daytime motor symptoms. A meta-analysis found that subthalamic DBS significantly improved Parkinson’s disease sleep scale scores, indicating better overall sleep quality, while also substantially improving motor function.¹⁴ A prospective study of 50 patients found that DBS improved subjective sleep quality and reduced daytime sleepiness.¹⁵ Some of this improvement likely comes from better motor control reducing nighttime stiffness and immobility, though DBS also appears to have more direct effects on sleep architecture. One study found that improvements in daytime sleepiness were correlated with stimulation of the limbic portion of the subthalamic nucleus, while sleep quality improvements were tied to stimulation of its motor portion, suggesting DBS affects sleep through multiple pathways.¹⁶

Circadian Rhythm Disruption in Parkinson’s Disease

Beyond the specific motor and sleep disorders, Parkinson’s disease appears to disrupt the body’s internal clock more broadly. The circadian system, which governs the roughly 24-hour cycle of sleep, wakefulness, hormone release, and body temperature, is affected in Parkinson’s patients. This manifests as irregular sleep-wake patterns, excessive daytime sleepiness, and altered timing of various biological functions. Both slow-wave sleep and REM sleep are notably disrupted in the disease.

The circadian dysfunction is not merely a side effect of poor nighttime sleep. Parkinson’s disease damages brain regions involved in circadian regulation, and this disruption may itself worsen disease progression, creating a negative feedback loop. Diurnal fluctuations in Parkinson’s symptoms, where some patients feel markedly better at certain times of day, likely reflect interactions between the circadian system and the dopamine pathways damaged by the disease. This is an area of growing research interest, because if circadian disruption accelerates neurodegeneration, then interventions targeting sleep timing, light exposure, and circadian regularity could potentially slow disease progression alongside traditional motor symptom treatments.

What Bed Partners Actually See

If you share a bed with someone who has Parkinson’s disease and you notice movement at night, the type of movement matters for figuring out what is going on and what to report to their neurologist. Rhythmic shaking of a hand or foot that looks like their daytime tremor almost always means they are not fully asleep, either still drifting off or briefly awakened, possibly from medication wearing off. Violent or dramatic movements like punching, kicking, or shouting during what appears to be deep sleep point toward RBD. Repetitive, periodic leg jerks every 20 to 40 seconds suggest PLMS. And long stretches of total stillness in one position, sometimes accompanied by complaints of stiffness or an inability to get comfortable, signal nocturnal hypokinesia.

Each of these has different implications for treatment. Tremor during awakenings might respond to adjusting the timing or formulation of evening medication. RBD requires safety precautions and potentially specific medication. PLMS and restless legs may be helped by dopamine agonists. And nocturnal hypokinesia often improves with sustained-release dopaminergic medications or, in more advanced cases, DBS. A sleep study can sort out which of these phenomena is occurring, since they can coexist in the same patient and the observer alone may not be able to distinguish between them reliably. Getting the right diagnosis matters, because the most common assumption, that the person is “just shaking in their sleep,” is almost always the wrong explanation.